Online Medication Assisted Treatment Education for Court Professionals
Need, Opportunities and Challenges
Bibliographic Data
| ID | 21645044 |
|---|---|
| Authors | Harlan Matusow (The Center For Human Development, New York, NY, corresponding author), Andrew Rosenblum (0000-0002-7372-9447, NDRI-USA, New York, NY), Chunki Fong (0000-0001-7026-5117, NDRI-USA, New York, NY) |
| Year | 2021 |
| Volume | 56 |
| Issue | 10 |
| Pages | 1439-1447 |
| Publication date | 2021-08-24 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | Substance Use & Misuse (JOURNAL) |
| Journal identifiers | ISSN: 1082-6084 • E-ISSN: 1532-2491 |
| Publisher | Informa UK Limited (PUBLISHER • GB) |
| DOI | 10.1080/10826084.2021.1936045 |
| PMID | 34154519 |
| OpenAlex | W3176741500 |
| Language | EN |
| Citations received | 5 |
| References cited | 31 |
Introduction Although medication-assisted treatment (MAT) effectively treats opioid use disorders (OUD), MAT access is restricted in criminal justice (CJ) settings. Previous studies have documented that stigma and limited knowledge about MAT are prevalent among CJ court personnel. We describe development and pilot testing of an eLearning intervention to improve MAT knowledge and increase MAT referrals in Ohio courts. Methods: Building upon a nationwide survey conducted in 2011 of drug courts and informed by MAT opinions from judges who supervised OUD clients, we developed two eLearning MAT modules. Judges completed a brief online MAT knowledge-attitude scale (K-A) before, after, and at 3 months. Judges were asked about MAT referrals pretest and 3 months later. Results: Sixty-three judges expressed interest in the study, 25 completed the pretest and viewed the modules, 11 completed a 3 month posttest. At pretest, K-A scores were significantly (p<.05) lower for agonist medications than for extended-release naltrexone (XR-NTX; Vivitrol). K-A scores improved at posttest for agonist medications (p<.05) but declined to pretest levels three months later. Three months after the pretest, buprenorphine referrals increased from 2.6% to 9.7% (p<.05). There was no significant difference on K-A scores for agonist medication between the Ohio sample (at pretest) and the 2011 sample. Conclusion: Although there is some indication that eLearning may have strengthened knowledge gains and increased buprenorphine referrals, a more robust eLearning intervention will likely be required to increase court personnel participation and sustain eLearning knowledge gains. Recruiting and sustaining judges’ participation in the study represented a significant study limitation
Medical education · Political science · Digital Mental Health Interventions · Medicine · Nursing · Opioid Use Disorder Treatment · Psychology · Psychopathy, Forensic Psychiatry, Sexual Offending
Barriers to drug treatment in police diversion programs and drug courts
A national survey of state laws regarding medications for opioid use disorder in problem-solving courts
Problem-Solving Court Staff Preferences for Educational Videos about Medications for Opioid Use Disorder
Linkage facilitation for opioid use disorder in criminal legal system contexts
Implementation of harm reduction strategies in criminal-legal systems
Internet-Based Learning in the Health Professions
Replication and Analysis of Ebbinghaus’ Forgetting Curve
Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword
Attitudes and Practices Regarding the Use of Methadone in US State and Federal Prisons
Improving Graduation Rates in Drug Court Through Employment and Schooling Opportunities and Medication-Assisted Treatment (MAT)
The First Comprehensive Program for Opioid Use Disorder in a US Statewide Correctional System
Using thematic analysis in psychology
| Unique citing works | 5 |
|---|---|
| Citations per year | 1.25 |
| Citation span | 2022 - 2025 (4) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 4 |